<DOC>
	<DOCNO>NCT00153140</DOCNO>
	<brief_summary>The purpose study compare safety efficacy extend polyethyleneglycol3350 use tegaserod patient chronic constipation .</brief_summary>
	<brief_title>Polyethyleneglycol3350 v Tegaserod Treatment Patients With Chronic Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Tegaserod</mesh_term>
	<mesh_term>Polyethylene glycol 3350</mesh_term>
	<criteria>Male female outpatient least 18 year age Constipated accord ROME I criteria If female childbearing potential , patient must surgically sterilize use oral contraceptive , depot contraceptive , double barrier method , intrauterine device , testify monogamous vasectomized partner , practice abstinence continue duration study Are otherwise good health , judge physical examination In investigator 's judgment , patient mentally competent sign instrument inform consent Patients heme positive stool screen associated hemorrhoid anal fissure . Patients hypo hyperthyroidism determine medical history . Patients severe renal impairment . Patients moderate severe hepatic impairment . Patients know suspected perforation obstruction . History gastric retention , inflammatory bowel disease , bowel resection , colostomy . Patients symptomatic gallbladder disease , suspect sphincter Oddi dysfunction , abdominal adhesion . Patients known history organic cause constipation . Patients currently take , plan take follow medication know effect bowel habit : Antidiarrheals Antacids contain magnesium aluminum salt Anticholinergics Antispasmodic agent Erythromycin macrolides Octreotide Lotronex , Zofran , 5HT3 antagonist Zelnorm , 5HT4 agonist Opiods/narcotic analgesic Prokinetics Serotonin reuptake inhibitor tricyclic antidepressant Calcium antagonist Patients breastfeed , pregnant , intend become pregnant study . Female patient childbearing potential refuse pregnancy test . Patients know allergy tegaserod ( excipients ) polyethyleneglycol . Patients , opinion investigator , include study reason , include inability follow study procedure . Patients , within past 30 day participate investigational clinical study . Patients undergone colonoscopy within 30 day screen Patients currently take , previously treat polyethyleneglycol3350 tegaserod .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>